Larvicidal activity of green synthesized iron oxide nanoparticles using Grevillea robusta Cunn. leaf extract against vector mosquitoes and their characterization

Antimicrobial and mosquito larvicidal activity of iron oxide nanoparticles phytosynthesized from the medicinal plant Andrographis serpyllifolia

“…The mosquito larvae (4 th instar) exposed to different concentrations of ASL•Fe2O3-NPs exhibited concentration-dependent mortality, while 42 h exposure resulted in higher mortality than 24 h exposure (Figure 5B). There has been a high degree of dose-dependent and exposure-time-dependent larvicidal activity against the vector mosquitoes, Anopheles stephensi and Aedes aegypti reported in a similar study which employed Fe2O3-NPs biosynthesized with the leaf extract of Grivillea robusta (Zargham et al, 2023). A maximum of 51.33% larval mortality was observed in 10 ppm ASL•Fe2O3-NPs after 48 h was recorded with a highly significant Chi-square values.…”

An Investigation into the Larvicidal Activity of Biologically Synthesized Silver and Copper Oxide Nanoparticles Against Mosquito Larvae

“…[3][4][5][6] The prevalence of these infections is staggering, with approximately 390 million cases annually, marked by an eight-fold increase in reported instances within the past two decades. [2][3][4][5][6] Furthermore, a staggering 3.9 billion people are at risk of infection. [3][4][5][6] Hence, disease prevention primarily centres on mosquito population management, often utilizing larvicides as a key strategy.…”

“…[2][3][4][5][6] Furthermore, a staggering 3.9 billion people are at risk of infection. [3][4][5][6] Hence, disease prevention primarily centres on mosquito population management, often utilizing larvicides as a key strategy. [5,6] Common larvicides encompass organophosphates (e. g., temephos), and the application of these agents to natural or artificial water bodies necessitates caution due to their potential impact on beneficial and non-target organisms.…”

“…[1][2][3][4][5] These mosquitoes are especially prevalent in urban and semi-urban environments, amplifying their impact as vectors of deadly diseases. [3][4][5][6] The prevalence of these infections is staggering, with approximately 390 million cases annually, marked by an eight-fold increase in reported instances within the past two decades. [2][3][4][5][6] Furthermore, a staggering 3.9 billion people are at risk of infection.…”

“…[3][4][5][6] Hence, disease prevention primarily centres on mosquito population management, often utilizing larvicides as a key strategy. [5,6] Common larvicides encompass organophosphates (e. g., temephos), and the application of these agents to natural or artificial water bodies necessitates caution due to their potential impact on beneficial and non-target organisms. Overreliance on synthetic chemical insecticides has led to reduced efficacy and the emergence of resistant insect populations.…”